2025 annual financial data
Syndax Pharmaceuticals 2025 Operating margin
Syndax Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was -158.45%.
Operating income was -273,084,000 USD and net income was -285,422,000 USD.
Operating cash flow was -322,980,000 USD.
Get free Syndax Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 172,352,000 USD
- Operating income
- -273,084,000 USD
- Net income
- -285,422,000 USD
- Operating cash flow
- -322,980,000 USD